<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Life</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Med Life</journal-id>
      <journal-id journal-id-type="publisher-id">JMedLife</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medicine and Life</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1844-122X</issn>
      <issn pub-type="epub">1844-3117</issn>
      <publisher>
        <publisher-name>Carol Davila University Press</publisher-name>
        <publisher-loc>Romania</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23599824</article-id>
      <article-id pub-id-type="pmc">3624652</article-id>
      <article-id pub-id-type="publisher-id">JMedLife-06-72</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Presentation</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hypokalemic periodic paralysis as first sign of thyrotoxicosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Trifanescu</surname>
            <given-names>RA</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
          <xref ref-type="aff" rid="A2">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Danciulescu Miulescu</surname>
            <given-names>R</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carsote</surname>
            <given-names>M</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Poiana</surname>
            <given-names>C</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
          <xref ref-type="aff" rid="A2">**</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>*</label>Department of Endocrinology, &#x201C;Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania</aff>
      <aff id="A2"><label>**</label>&#x201C;C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania</aff>
      <author-notes>
        <corresp><bold>Correspondence to:</bold>: Catalina Poiana, MD, PhD, Associate Professor of Endocrinology,
Endocrinology Department, &#x201C;Carol Davila" University of Medicine and Pharmacy,
34-36 Aviatorilor Blvd., code 011863, Bucharest, Romania,
Phone/Fax: + 4021 317 7430; E-mail: endoparhon@gmail.com
</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <volume>6</volume>
      <issue>1</issue>
      <fpage>72</fpage>
      <lpage>75</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;Carol Davila University Press
</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is 
an open-access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work 
is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Background: periodic paralysis related to hypokalemia is seldom reported in thyrotoxicosis, and it usually occurs in Asian males.</p>
        <p>Patients and methods: Two Romanian (Caucasian) young patients presented with hypokalemic paralysis. TSH, FT4, TT3 was measured by immunochemiluminescence.</p>
        <p>Case report 1. Patient O.R, aged 19, presented marked asthenia and lower limbs paralysis, following high carbohydrate meal. He declared 10 kg weight loss on hypocaloric diet and mild sweating. Biochemical data revealed moderate hypokalemia (K+=2.6 mmol/L) and thyrotoxicosis (TSH&lt;0.03 mIU/L, FT4=30 pmol/L, TT3=315 ng/dL). </p>
        <p> Case report 2. Patient T.A., aged 18, presented 2 episodes of weakness and flaccid paralysis, with hypokalemia, precipitated by effort, without any sign of thyrotoxicosis. Biochemical data revealed severe hypokalemia (K+=1.8 mmol/L) and thyrotoxicosis (TSH&lt;0.03 mIU/L, FT4=24 pmol/L, TT3=190 ng/dL). Treatment with intravenous potassium, thereafter methimazole and propranolol were administered in both cases, with the maintenance of normal kalemia and thyrotoxicosis&#x2019; control.</p>
        <p> Conclusion: these 2 cases of hypokalemic periodic paralysis occurring in young Caucasian teenagers with mild thyrotoxicosis underlined the importance of thyroid screening in patients with symptomatic hypokalemia, even in the absence of symptoms and signs of thyrotoxicosis.
</p>
        <p>Abbreviations: THPP=Thyrotoxic periodic paralysis, BMI=body mass index, TRAb=TSH receptor antibody, ECG=electrocardiogram.</p>
      </abstract>
      <kwd-group>
        <kwd>hypokalemic paralysis</kwd>
        <kwd>thyrotoxicosis</kwd>
        <kwd>teenagers</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Hypokalemia with acute paralysis is a medical emergency. Up to 43.3% of the patients with hypokalemic paralysis had a secondary cause, 16.6-32% showing thyrotoxic paralysis [<bold><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></bold>].
Thyrotoxic periodic paralysis (THPP) is an unusual complication of thyrotoxicosis, that manifests as acute episodes of muscle weakness associated with hypokalemia [<bold><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref></bold>]. The disease primarily affects people of Asian descent, but also other ethnic groups [<bold><xref ref-type="bibr" rid="R5">5</xref></bold>] such as Europeans [<bold><xref ref-type="bibr" rid="R6">6</xref></bold>], Hispanics [<bold><xref ref-type="bibr" rid="R7">7</xref></bold>], native Americans [<bold><xref ref-type="bibr" rid="R8">8</xref></bold>]. THPP predominantly affects males [3,9].
THPP was reported more frequently in Graves disease [<bold><xref ref-type="bibr" rid="R10">10</xref></bold>], but also in toxic multinodular goiter [<bold><xref ref-type="bibr" rid="R11">11</xref></bold>], toxic thyroid adenoma [<bold><xref ref-type="bibr" rid="R12">12</xref></bold>], TSH secreting pituitary adenomas [<bold><xref ref-type="bibr" rid="R13">13</xref></bold>], painless thyroiditis [<bold><xref ref-type="bibr" rid="R14">14</xref></bold>], in patients with Jodbasedow thyrotoxicosis [<bold><xref ref-type="bibr" rid="R15">15</xref></bold>] and in patients taking levothyroxine [<bold><xref ref-type="bibr" rid="R16">16</xref></bold>].
</p>
    </sec>
    <sec sec-type="methods">
      <title>Patients and methods</title>
      <p>Two young, non-consanguineous Caucasian patients (18 and 19 years) initially presented with periodic hypokalemic paralysis. They did not have Asian ancestors, or a familial history of periodic paralysis, or personal history of distal renal tubular acidosis, primary hyperaldosteronism or Bartter-like syndrome. Both patients denied diarrhea, diuretics, licorice or alcohol use. </p>
      <p> TSH, FT4, TT4, TT3 were measured by immunochemiluminescence, upright aldosterone by ELISA, plasma 8 a.m. cortisol and direct rennin by immunochemiluminescence.
</p>
    </sec>
    <sec>
      <title>Case reports</title>
      <p>Case 1, O.R., male, aged 19, overweight (BMI=27.8 kg/m2), presented with marked asthenia and lower limbs paralysis. The symptoms had abrupt onset in the morning, after a rich carbohydrate meal. The patient declared 10 kg weight loss on hypocaloric diet and mild sweating. Neurological exam showed symmetrical, lower limbs flaccid paresis. Biochemical assessment revealed hyperglycemia (126 mg/dL) and moderate hypokalemia (2.6 mmol/L). Intravenous potassium supplements were administered with normalization of serum potassium levels. In the endocrine department, the physical exam revealed mild tachycardia, small diffuse goiter and tremor, without exophthalmia. Hormonal assessment revealed thyrotoxicosis (TSH&lt;0.03 mIU/L, FT4=30.6 pmol/L, TT3=315 ng/dL); TSH receptor antibodies (TRAb) were positive (<bold><xref ref-type="table" rid="T1">Table 1</xref></bold>). Oral glucose tolerance test was normal. After restoration of normal serum potassium levels, potassium excretion was normal (31.6 mmoL/24 hours).
Case 2, T. A., male, aged 18, presented with marked asthenia and quadriplegia with abrupt onset after an intensive physical effort. Neurological exam showed flaccid limbs paralysis. Severe hypokalemia (1.8 mmol/L) was present. Intravenous potassium supplements were administered with normalization of serum potassium levels. In the endocrine department, physical exam revealed small diffuse goiter without tachycardia, tremor or exophthalmia. Hormonal assessment revealed mild thyrotoxicosis (TSH&lt;0.03 mIU/L, FT4=24 pmol/L, TT3=190 ng/dL) (<bold><xref ref-type="table" rid="T1">Table 1</xref></bold>). After the restoration of normal serum potassium levels, renal potassium excretion was normal (51.8 mmoL/24 hours).
In both patients, thyroid ultrasound revealed hypoechoic, diffuse goiter; there were no signs of hypercortisolism and adrenal assessment was normal (<bold><xref ref-type="table" rid="T1">Table 1</xref></bold>).
</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Clinical and biochemical features at the onset of hypokalemic paralysis</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">Case 1</th>
              <th align="center" rowspan="1" colspan="1">Case 2</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <th align="left" rowspan="1" colspan="1">Symptoms</th>
              <th align="left" rowspan="1" colspan="1">Marked asthenia
Lower limbs paralysis
</th>
              <th align="left" rowspan="1" colspan="1">Muscle weakness
Flaccid quadriplegia
</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Precipitant factor</th>
              <th align="left" rowspan="1" colspan="1">Hyperglycaemia (126 mg/dL)</th>
              <th align="left" rowspan="1" colspan="1">Physical effort</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">BMI(kg/m2)</th>
              <th align="left" rowspan="1" colspan="1">27.8</th>
              <th align="left" rowspan="1" colspan="1">23.2</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">K+(mmol/L)</th>
              <th align="left" rowspan="1" colspan="1">2.6</th>
              <th align="left" rowspan="1" colspan="1">1.8</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Na+(mmoL/L)</th>
              <th align="left" rowspan="1" colspan="1">143</th>
              <th align="left" rowspan="1" colspan="1">140</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">TSH(mIU/L)</th>
              <th align="left" rowspan="1" colspan="1">&lt;0.03</th>
              <th align="left" rowspan="1" colspan="1">&lt;0.03</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">FT4(pmol/L)</th>
              <th align="left" rowspan="1" colspan="1">30.6</th>
              <th align="left" rowspan="1" colspan="1">24</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">TT3(ng/dL)</th>
              <th align="left" rowspan="1" colspan="1">315</th>
              <th align="left" rowspan="1" colspan="1">190</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Thyroid ultrasound</th>
              <th align="left" rowspan="1" colspan="1">Hypoechoic, diffuse goiter</th>
              <th align="left" rowspan="1" colspan="1">Diffuse goiter</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Plasma 8 a.m. cortisol after 1 mg DXM overnight</th>
              <th align="left" rowspan="1" colspan="1">0.87</th>
              <th align="left" rowspan="1" colspan="1">0.57</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Aldosterone (ng/dL)/direct renin (ng/L)</th>
              <th align="left" rowspan="1" colspan="1">0.8</th>
              <th align="left" rowspan="1" colspan="1">1</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Adrenal imaging</th>
              <th align="left" rowspan="1" colspan="1">Normal ultrasound</th>
              <th align="left" rowspan="1" colspan="1">Normal CT scan</th>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Antithyroid drugs (Methimazole 30 &gt; 20 &gt; 10 &gt; 5 mg/day) and non-selective &#x3B2; blockers (Propranolol 120 &gt; 60 &gt; 40 &gt; 30 mg/day) treatment were administered in both patients, with long-term maintenance of normal serum potassium levels and progressive normalization of TSH and FT4 levels (<bold><xref ref-type="table" rid="T2">Table 2</xref></bold>). Antithyroid drugs&#x2019; treatment duration was of 18 months. No recurrence of the paralysis has been noted during follow-up. </p>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p>Biochemical data after 3 months treatment with antithyroid drugs and non-selective &#x3B2; blockers</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="center" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">Case 1</th>
              <th align="center" rowspan="1" colspan="1">Case 2</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <th align="left" rowspan="1" colspan="1">K+(mmol/L)</th>
              <th align="left" rowspan="1" colspan="1">4.5</th>
              <th align="left" rowspan="1" colspan="1">5</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">TSH(mIU/L)</th>
              <th align="left" rowspan="1" colspan="1">0.3</th>
              <th align="left" rowspan="1" colspan="1">0.09</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">FT4(pmol/L)</th>
              <th align="left" rowspan="1" colspan="1">14</th>
              <th align="left" rowspan="1" colspan="1">12.6</th>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>To our knowledge, these cases are the first Romanian published cases of hypokalemic thyrotoxic paralysis so far.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Both our patients are males. THPP had a higher predilection for men than for women [<bold><xref ref-type="bibr" rid="R4">4</xref></bold>]. The disease occurred especially in young adults [<bold><xref ref-type="bibr" rid="R17">17</xref></bold>]. </p>
      <p> In our patients, THPP occurred at night and early after awakening, respectively. Early morning paralysis was reported as the first manifestation of hyperthyroidism both in Asian men [<bold><xref ref-type="bibr" rid="R18">18</xref></bold>] and in Caucasians [<bold><xref ref-type="bibr" rid="R19">19</xref></bold>]. Precipitating factors included sleep at night, hot weather, upper respiratory tract infections, excessive physical activities [<bold><xref ref-type="bibr" rid="R17">17</xref></bold>], excessive alcohol intake [<bold><xref ref-type="bibr" rid="R20">20</xref></bold>], high carbohydrate intake [<bold><xref ref-type="bibr" rid="R21">21</xref></bold>]. </p>
      <p> Both our patients showed mild thyrotoxicosis. Many affected patients do not have obvious symptoms and signs of thyrotoxicosis [<bold><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R22">22</xref></bold>].</p>
      <p> Both patients showed sinus tachycardia, U waves, without ventricular arrhythmia on electrocardiogram (ECG). ECG manifestations in THPP were slightly different as compared with non-thyrotoxic periodic paralysis, at similar low K+ levels: heart rate, PR interval, and QRS voltage were significantly higher [<bold><xref ref-type="bibr" rid="R23">23</xref></bold>]. Young patients with THPP complicated by acute hypercapnic respiratory failure and ventricular tachycardia [<bold><xref ref-type="bibr" rid="R22">22</xref></bold>] or with thyroid storm, psychosis and episodic acute respiratory failure [<bold><xref ref-type="bibr" rid="R5">5</xref></bold>] were reported.</p>
      <p> The underlying mechanism of THPP is an acute extra to intracellular shift of potassium, mainly into the muscles, due to the stimulation of the activity of the Na-K-ATP-ase pump by thyroid hormones, via beta-adrenergic stimulation [<bold><xref ref-type="bibr" rid="R3">3</xref></bold>]. Genetic predisposition plays a role in the pathogenesis of thyrotoxic hypokalemic periodic paralysis; polymorphisms of the calcium channel alpha1-subunit gene [<bold><xref ref-type="bibr" rid="R24">24</xref></bold>], mutations in SCN4A or CACNA1S [<bold><xref ref-type="bibr" rid="R25">25</xref></bold>] were reported. Up to 33% of THPP patients showed a mutation in Kir2.6 gene, regulated by thyroid hormones [<bold><xref ref-type="bibr" rid="R26">26</xref></bold>]. Single nucleotide polymorphisms of gamma-aminobutyric acid receptor alpha3 subunit were associated with THPP [<bold><xref ref-type="bibr" rid="R27">27</xref></bold>]. </p>
      <p> Treatment of THPP implies two steps: the hypokalemia correction and the euthyroidism restoring [<bold><xref ref-type="bibr" rid="R4">4</xref></bold>]. Both our patients initially received intravenous potassium chloride supplementation; correction of hypokalemia by potassium supplementation, in order to avoid fatal cardiac arrhythmias and to reverse muscle weakness is mandatory [<bold><xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R3">3</xref></bold>]. However, the patients do not have a total body deficiency of potassium, so aggressive potassium supplementation should be avoided, because it can result in rebound hypokalemia [<bold><xref ref-type="bibr" rid="R29">29</xref></bold>]. Potassium supplementation should be given as small as possible (&lt;10 mmol/hr) [<bold><xref ref-type="bibr" rid="R28">28</xref></bold>]. Intravenous glucose solution should be avoided, because it could aggravate hypokalemia, leading to death [<bold><xref ref-type="bibr" rid="R30">30</xref></bold>]. </p>
      <p> The second step is the treatment with antithyroid drugs and beta-blockers. Nonselective beta-adrenergic blockers can ameliorate and prevent recurrence of the paralytic attacks. Both our cases received propranolol 120 mg/day and antithyroid drugs. </p>
      <p> In both presented cases, no recurrence of the paralysis has been noted within the first 3 years after diagnosis. However, before achieving the euthyroid status, the rate of recurrent attacks could be up to 62.2% [<bold><xref ref-type="bibr" rid="R17">17</xref></bold>]. This episodic paralysis will remit with definitive control of hyperthyroidism [<bold><xref ref-type="bibr" rid="R3">3</xref></bold>]. Both our patients refused definitive surgical treatment of thyrotoxicosis and underwent regular thyroid follow-up.
</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Thyrotoxic hypokalemic periodic paralysis, although rare in Caucasian men, should be considered in the differential diagnosis of hypokalemic paralysis. Thyroid screening is mandatory in patients with muscular paralysis associated with hypokalemia.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maurya </surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Kalita </surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Spectrum of hypokalaemic periodic paralysis in a tertiary care centre in India</article-title>
          <source>Postgrad Med J</source>
          <year>2010</year>
          <volume>86</volume>
          <fpage>692</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="pmid">20935343</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phakdeekitcharoen </surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ruangraksa </surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Hypokalaemia and paralysis in the Thai population</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>2013</fpage>
          <lpage>2018</lpage>
          <pub-id pub-id-type="pmid">15187194</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>3. Kung </surname>
              <given-names>AW</given-names>
            </name>
          </person-group>
          <article-title>Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2006</year>
          <volume>91</volume>
          <fpage>2490</fpage>
          <lpage>2495</lpage>
          <pub-id pub-id-type="pmid">16608889</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pothiwala </surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Levine </surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Analytic review: thyrotoxic periodic paralysis: a review</article-title>
          <source>J Intensive Care Med</source>
          <year>2010</year>
          <volume>25</volume>
          <fpage>71</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">20089526</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbasi </surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sharif </surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Hypokalemic thyrotoxic periodic paralysis with thyrotoxic psychosis and hypercapnic respiratory failure</article-title>
          <source>Am J Med Sci</source>
          <year>2010</year>
          <volume>340</volume>
          <fpage>147</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">20581656</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barahona </surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Vinagre </surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic periodic paralysis: a case report and literature review</article-title>
          <source>Clin Med Res</source>
          <year>2009</year>
          <volume>7</volume>
          <fpage>96</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">19625499</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zumo </surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Terzian </surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic hypokalemic periodic paralysis in a Hispanic male</article-title>
          <source>J Natl Med Assoc</source>
          <year>2002</year>
          <volume>94</volume>
          <fpage>383</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">12069220</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seshadri </surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Frank </surname>
              <given-names>KD</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic hypokalemic periodic paralysis in a Native American patient: case report and literature review</article-title>
          <source>Endocr Pract</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>362</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">15259121</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellgren </surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bleskestad </surname>
              <given-names>IH</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature</article-title>
          <source>Thyroid</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>77</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">11838735</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erem </surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic hypokalemic periodic paralysis in a Turkish male with graves' disease: a rare case report and review of the literature</article-title>
          <source>Endocrine</source>
          <year>2005</year>
          <volume>27</volume>
          <fpage>63</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">16077173</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arenas Gracia </surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mata </surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Lymphocytic colitis: hypopotassemia as a complication and an association with toxic multinodular goiter</article-title>
          <source>Gastroenterol Hepatol</source>
          <year>2000</year>
          <volume>23</volume>
          <fpage>75</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">10726387</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tagami </surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Usui </surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Toxic thyroid adenoma presenting as hypokalemic periodic paralysis</article-title>
          <source>Endocr J</source>
          <year>2007</year>
          <volume>54</volume>
          <fpage>797</fpage>
          <lpage>803</lpage>
          <pub-id pub-id-type="pmid">17917308</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pappa </surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Papanastasiou </surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic periodic paralysis as the first manifestation of a thyrotropin-secreting pituitary adenoma</article-title>
          <source>Hormones</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>82</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">20363726</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh </surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Ahn </surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic periodic paralysis associated with transient thyrotoxicosis due to painless thyroiditis</article-title>
          <source>J Korean Med </source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>822</fpage>
          <lpage>826</lpage>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kane </surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Busch </surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Drug-induced thyrotoxic periodic paralysis</article-title>
          <source>Ann Pharmacother</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>778</fpage>
          <lpage>781</lpage>
          <pub-id pub-id-type="pmid">16537816</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen </surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Fang </surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction</article-title>
          <source>Ren Fail</source>
          <year>2001</year>
          <volume>23</volume>
          <fpage>139</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="pmid">11256524</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsieh </surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Lyu </surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks</article-title>
          <source>Eur J Neurol</source>
          <year>2008</year>
          <volume>15</volume>
          <fpage>559</fpage>
          <lpage>564</lpage>
          <pub-id pub-id-type="pmid">18410374</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goh </surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic periodic paralysis: reports of seven patients presenting with weakness in an Asian emergency department</article-title>
          <source>Emerg Med J</source>
          <year>2002</year>
          <volume>19</volume>
          <fpage>78</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="pmid">11777887</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reisin </surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Martinez </surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic periodic paralysis in caucasians. Report of 8 cases</article-title>
          <source>Neurologia</source>
          <year>2000</year>
          <volume>15</volume>
          <fpage>222</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">11002697</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu </surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Tseng </surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Potassium chloride supplementation alone may not improve hypokalemia in thyrotoxic hypokalemic periodic paralysis</article-title>
          <source>J Emerg Med</source>
          <year>2007</year>
          <volume>32</volume>
          <fpage>263</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="pmid">17394988</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Hennawy </surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Nesa </surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic hypokalemic periodic paralysis triggered by high carbohydrate diet</article-title>
          <source>Am J Ther</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>499</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="pmid">17890941</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu </surname>
              <given-names>CZ</given-names>
            </name>
            <name>
              <surname>Wu </surname>
              <given-names>YK</given-names>
            </name>
          </person-group>
          <article-title>Thyrotoxic periodic paralysis complicated by acute hypercapnic respiratory failure and ventricular tachycardia</article-title>
          <source>Thyroid</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>1321</fpage>
          <lpage>1324</lpage>
          <pub-id pub-id-type="pmid">19014279</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu </surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Lin </surname>
              <given-names>YF</given-names>
            </name>
          </person-group>
          <article-title>Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis</article-title>
          <source>Am J Med Sci</source>
          <year>2003</year>
          <volume>326</volume>
          <fpage>128</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">14501227</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kung </surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Lau </surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2004</year>
          <volume>89</volume>
          <fpage>1340</fpage>
          <lpage>1345</lpage>
          <pub-id pub-id-type="pmid">15001631</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raja Rayan </surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Hanna </surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis</article-title>
          <source>Curr Opin Neurol</source>
          <year>2010</year>
          <volume>23</volume>
          <fpage>466</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="pmid">20634695</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan </surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>da Silva </surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis</article-title>
          <source>Cell</source>
          <year>2010</year>
          <volume>140</volume>
          <fpage>88</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">20074522</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jongjaroenprasert </surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chanprasertyotin </surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Association of genetic variants in GABRA3 gene and thyrotoxic hypokalaemic periodic paralysis in Thai population</article-title>
          <source>Clin Endocrinol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>646</fpage>
          <lpage>651</lpage>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu </surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Hsu </surname>
              <given-names>YJ</given-names>
            </name>
          </person-group>
          <article-title>Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis</article-title>
          <source>Am J Emerg Med</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>544</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="pmid">15666258</pub-id>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chou </surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Tsao </surname>
              <given-names>YT</given-names>
            </name>
          </person-group>
          <article-title>An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents</article-title>
          <source>Am J Med Sci</source>
          <year>2009</year>
          <volume>337</volume>
          <fpage>71</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">19002009</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen </surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Schneider </surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Fatality after cardiac arrest in thyrotoxic periodic paralysis due to profound hypokalemia resulting from intravenous glucose administration and inadequate potassium replacement</article-title>
          <source>Thyroid</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>969</fpage>
          <lpage>972</lpage>
          <pub-id pub-id-type="pmid">22827749</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
